{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-200869","form_type":"8-K","ticker":"BHC","cik":"0000885590","company_name":"Bausch Health Companies Inc.","filed_at":"2025-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.586277+00:00","generated_at":"2026-05-17T06:56:39.340379+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bausch Health completes acquisition of DURECT for $1.75/share plus CVRs","bullets":["Tender offer closed with 62% of DURECT shares (19.98M) validly tendered and accepted.","Price: $1.75 per share in cash plus one contingent value right per share.","CVRs provide up to $350M aggregate milestone payments (net of retention bonuses).","BHC Lyon merged into DURECT; DURECT now a wholly-owned subsidiary of Bausch Health Americas.","Transaction consummated on September 11, 2025 after all conditions satisfied."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-200869","json":"https://secwatch.observer/filing/0001193125-25-200869.json","markdown":"https://secwatch.observer/filing/0001193125-25-200869.md","text":"https://secwatch.observer/filing/0001193125-25-200869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885590/000119312525200869/0001193125-25-200869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885590/000119312525200869/d934691d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:56:39.340379+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}